GSE255685 provides per-sample processed expression-score files; values are not raw counts.
| Gene | Pathway | Expression (rlog) | vs Cohort | Cohort Median | %ile |
|---|---|---|---|---|---|
| APOE | Lipid Metabolism | 1.72 | bar=donor line=cohort median | 2.02 | 3.4% |
| FOXO3 | Insulin/IGF-1 Signaling | 9.56 | bar=donor line=cohort median | 9.99 | 5.2% |
| CETP | Lipid Metabolism | 6.90 | bar=donor line=cohort median | 5.05 | 99.8% |
| SIRT6 | Sirtuin Family | 8.67 | bar=donor line=cohort median | 8.34 | 90.1% |
| SIRT1 | Sirtuin Family | 8.53 | bar=donor line=cohort median | 8.72 | 22.0% |
| SIRT3 | Sirtuin Family | 7.26 | bar=donor line=cohort median | 7.49 | 11.3% |
| IGF1R | Insulin/IGF-1 Signaling | 9.43 | bar=donor line=cohort median | 10.21 | 3.8% |
| KLOTHO | Anti-aging | 2.94 | bar=donor line=cohort median | 2.51 | 93.7% |
| APOC3 | Lipid Metabolism | -2.11 | bar=donor line=cohort median | -2.11 | 61.1% |
| IL6 | Inflammation | 1.00 | bar=donor line=cohort median | 1.16 | 12.0% |
| TERT | Telomere Maintenance | 1.29 | bar=donor line=cohort median | 1.51 | 5.2% |
| IRS2 | Insulin/IGF-1 Signaling | 8.75 | bar=donor line=cohort median | 9.81 | 0.2% |
| TP53 | Tumor Suppression | 9.25 | bar=donor line=cohort median | 8.92 | 94.8% |
| SHC1 | Signal Transduction | 9.93 | bar=donor line=cohort median | 9.35 | 99.8% |
| ACE | Signal Transduction | 4.68 | bar=donor line=cohort median | 4.64 | 54.3% |
| # | Gene | ID | Type | Expression (Expression score) | Count |
|---|---|---|---|---|---|
| 1 | MTCO2P12 | 22.4 | 0 | ||
| 2 | HLA-C | 16.8 | 0 | ||
| 3 | B2M | 16.8 | 0 | ||
| 4 | ACTB | 16.7 | 0 | ||
| 5 | MT-RNR2 | 16.4 | 0 | ||
| 6 | HLA-B | 16.3 | 0 | ||
| 7 | MT-CO1 | 16.2 | 0 | ||
| 8 | HLA-E | 16.2 | 0 | ||
| 9 | CSF3R | 16.0 | 0 | ||
| 10 | EEF1A1 | 16.0 | 0 |
| # | Gene | Type | Expression | vs Cohort | Group Median | Cohort Median | %ile |
|---|---|---|---|---|---|---|---|
| 1 | S100A8 | 12.9 | bar=donor line=cohort median | 13.8 | 14.2 | 8.4% | |
| 2 | S100A9 | 15.0 | bar=donor line=cohort median | 15.3 | 15.5 | 13.4% | |
| 3 | IL1B | 10.2 | bar=donor line=cohort median | 9.5 | 9.3 | 93.4% | |
| 4 | CXCL8 | 8.2 | bar=donor line=cohort median | 10.6 | 11.4 | 2.0% |
| # | Gene | Type | Expression | vs Cohort | Group Median | Cohort Median | %ile |
|---|---|---|---|---|---|---|---|
| 5 | MPO | 6.7 | bar=donor line=cohort median | 6.0 | 6.1 | 78.7% | |
| 6 | FCGR3B | 15.2 | bar=donor line=cohort median | 14.6 | 14.7 | 85.8% |
| # | Gene | Type | Expression | vs Cohort | Group Median | Cohort Median | %ile |
|---|---|---|---|---|---|---|---|
| 7 | LYZ | 15.1 | bar=donor line=cohort median | 14.3 | 14.3 | 96.6% |
| # | Gene | Type | Expression | vs Cohort | Group Median | Cohort Median | %ile |
|---|---|---|---|---|---|---|---|
| 8 | CD3D | 9.7 | bar=donor line=cohort median | 10.2 | 10.4 | 3.8% | |
| 9 | CD3E | 12.0 | bar=donor line=cohort median | 11.9 | 12.0 | 50.4% |
| # | Gene | Type | Expression | vs Cohort | Group Median | Cohort Median | %ile |
|---|---|---|---|---|---|---|---|
| 10 | MS4A1 | 9.8 | bar=donor line=cohort median | 11.0 | 10.9 | 0.2% |
| # | Gene | Type | Expression | vs Cohort | Group Median | Cohort Median | %ile |
|---|---|---|---|---|---|---|---|
| 11 | NKG7 | 12.4 | bar=donor line=cohort median | 11.7 | 11.7 | 85.1% | |
| 12 | GNLY | 12.3 | bar=donor line=cohort median | 12.0 | 12.1 | 61.5% |
| # | Gene | Type | Expression | vs Cohort | Group Median | Cohort Median | %ile |
|---|---|---|---|---|---|---|---|
| 16 | MT-CO1 | 16.2 | bar=donor line=cohort median | 16.4 | 16.4 | 13.4% | |
| 17 | MT-CO2 | 14.9 | bar=donor line=cohort median | 15.2 | 15.3 | 6.6% | |
| 18 | MT-ND1 | 14.8 | bar=donor line=cohort median | 15.0 | 15.2 | 7.0% |